Advances in lipid management: current challenges and new horizons

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide, with elevated low-density lipoprotein cholesterol being a major modifiable risk factor. Effective lipid management is crucial for CVD prevention, yet a substantial proportion of patients do not achieve guideline-recommended lipid goals. This treatment gap underscores the need for implementation strategies to optimise the use of currently available therapies for lipid lowering. Furthermore, the landscape of lipid management is rapidly evolving, with several novel therapies showing promise in clinical trials.